"Sarcoidosis, Pulmonary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Sarcoidosis affecting predominantly the lungs, the site most frequently involved and most commonly causing morbidity and mortality in sarcoidosis. Pulmonary sarcoidosis is characterized by sharply circumscribed granulomas in the alveolar, bronchial, and vascular walls, composed of tightly packed cells derived from the mononuclear phagocyte system. The clinical symptoms when present are dyspnea upon exertion, nonproductive cough, and wheezing. (Cecil Textbook of Medicine, 19th ed, p431)
| Descriptor ID |
D017565
|
| MeSH Number(s) |
C08.381.483.725 C15.604.515.827.725
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Sarcoidosis, Pulmonary".
Below are MeSH descriptors whose meaning is more specific than "Sarcoidosis, Pulmonary".
This graph shows the total number of publications written about "Sarcoidosis, Pulmonary" by people in this website by year, and whether "Sarcoidosis, Pulmonary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2006 | 0 | 2 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Sarcoidosis, Pulmonary" by people in Profiles.
-
Immune mapping of human tuberculosis and sarcoidosis lung granulomas. Front Immunol. 2023; 14:1332733.
-
Atypical presentation of cardiac sarcoidosis: role of multimodality imaging and review of literature. BMJ Case Rep. 2020 Feb 10; 13(2).
-
18F-FDG PET/CT in Pulmonary Sarcoidosis:Quantifying Inflammation by the TLG index. Expert Rev Respir Med. 2020 01; 14(1):103-110.
-
The Pathogenesis of Pulmonary Sarcoidosis and Implications for Treatment. Chest. 2018 06; 153(6):1432-1442.
-
Local and Systemic CD4+ T Cell Exhaustion Reverses with Clinical Resolution of Pulmonary Sarcoidosis. J Immunol Res. 2017; 2017:3642832.
-
Lung transplantation for pulmonary sarcoidosis. Twenty-five years of experience in the USA. Thorax. 2016 Apr; 71(4):378-9.
-
Beyond metastatic disease: a pictorial review of multinodular lung disease with computed tomographic pathologic correlation. Can Assoc Radiol J. 2015 Feb; 66(1):16-23.
-
Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. Am J Respir Crit Care Med. 2014 Sep 01; 190(5):560-71.
-
Images in clinical medicine. Tattoos and sarcoidosis. N Engl J Med. 2014 Jun 05; 370(23):e34.
-
Visual hallucinations (Charles Bonnet syndrome) associated with neurosarcoidosis. Middle East Afr J Ophthalmol. 2013 Oct-Dec; 20(4):369-71.